Reviewed,
UniProtKB/Swiss-Prot O14495 (LPP3_HUMAN)
Last modified
July 7, 2009.
Version 74.
History...
Clusters with 100%,
90%,
50% identity |
Documents (3) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Lipid phosphate phosphohydrolase 3 EC=3.1.3.4 Alternative name(s): Phosphatidic acid phosphatase 2b PAP2-beta Short name=PAP-2b Short name=PAP2b Phosphatidate phosphohydrolase type 2b Vascular endothelial growth factor and type I collagen-inducible protein Short name=VCIP | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 311 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Catalyzes the conversion of phosphatidic acid (PA) to diacylglycerol (DG). In addition it hydrolyzes lysophosphatidic acid (LPA), ceramide-1-phosphate (C-1-P) and sphingosine-1-phosphate (S-1-P). The relative catalytic efficiency is LPA = PA > C-1-P > S-1-P. May be involved in cell adhesion and in cell-cell interactions. |
| Catalytic activity | A 3-sn-phosphatidate + H2O = a 1,2-diacyl-sn-glycerol + phosphate. |
| Enzyme regulation | Inhibited by sphingosine, zinc ions and propanolol. Not inhibited by N-ethylmaleimide treatment. |
| Subunit structure | Homodimer. This complex seems not to be involved in substrate recognition, it may confer only structural or functional stability. Ref.7 |
| Subcellular location | Golgi apparatus › trans-Golgi network membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein. |
| Tissue specificity | Ubiquitously expressed. Highly expressed in heart and placenta. |
| Induction | By epidermal growth factor (EGF), vascular endothelial growrh factor (VEGF), basic fibroblast growth factor (bFGF) and phorbol myristate acetate (PMA). Ref.1 |
| Post-translational modification | N-glycosylated. Contains high-mannose oligosaccharides. |
| Sequence similarities | Belongs to the PA-phosphatase related phosphoesterase family. |
| Sequence caution | The sequence AAB50222.1 differs from that shown. Reason: Frameshift at position 225. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell membrane Golgi apparatus Membrane |
| Domain | Transmembrane |
| Molecular function | Hydrolase |
| PTM | Glycoprotein Phosphoprotein |
| Technical term | Complete proteome |
| Gene Ontology (GO) | |
| Biological process | germ cell migration Ref.1 Traceable author statement. Source: ProtInc |
| Cellular component | Golgi apparatus Inferred from electronic annotation. Source: UniProtKB-SubCell cytosol Ref.2Inferred from Experiment. Source: Reactome integral to membraneInferred from electronic annotation. Source: UniProtKB-KW plasma membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | phosphatidate phosphatase activity Ref.2 Inferred from Experiment. Source: Reactome phosphoprotein phosphatase activity Ref.2Traceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 311 | 311 | Lipid phosphate phosphohydrolase 3 | PRO_0000220912 | |||||
Regions | |||||||||
| Topological domain | 1 – 33 | 33 | Cytoplasmic Potential | ||||||
| Transmembrane | 34 – 54 | 21 | Potential | ||||||
| Topological domain | 55 – 85 | 31 | Lumenal Potential | ||||||
| Transmembrane | 86 – 106 | 21 | Potential | ||||||
| Topological domain | 107 – 122 | 16 | Cytoplasmic Potential | ||||||
| Transmembrane | 123 – 143 | 21 | Potential | ||||||
| Topological domain | 144 – 193 | 50 | Lumenal Potential | ||||||
| Transmembrane | 194 – 214 | 21 | Potential | ||||||
| Topological domain | 215 – 227 | 13 | Cytoplasmic Potential | ||||||
| Transmembrane | 228 – 248 | 21 | Potential | ||||||
| Topological domain | 249 – 257 | 9 | Lumenal Potential | ||||||
| Transmembrane | 258 – 278 | 21 | Potential | ||||||
| Topological domain | 279 – 311 | 33 | Cytoplasmic Potential | ||||||
Amino acid modifications | |||||||||
| Modified residue | 19 | 1 | Phosphoserine Ref.9 Ref.10 | ||||||
| Modified residue | 110 | 1 | Phosphotyrosine Ref.8 | ||||||
| Modified residue | 297 | 1 | Phosphoserine Ref.9 Ref.10 | ||||||
| Glycosylation | 170 | 1 | N-linked (GlcNAc...) Potential | ||||||
Experimental info | |||||||||
| Sequence conflict | 282 | 1 | T → M in AAH09196. Ref.6 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning and characterization of two human isozymes of Mg2+-independent phosphatidic acid phosphatase." Kai M., Wada I., Imai S., Sakane F., Kanoh H. J. Biol. Chem. 272:24572-24578(1997) [PubMed: 9305923] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, INDUCTION. |
| [2] | "Human type 2 phosphatidic acid phosphohydrolases. Substrate specificity of the type 2a, 2b, and 2c enzymes and cell surface activity of the 2a isoform." Roberts R., Sciorra V.A., Morris A.J. J. Biol. Chem. 273:22059-22067(1998) [PubMed: 9705349] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION. |
| [3] | "Regulation of cell-cell interactions by phosphatidic acid phosphatase 2b/VCIP." Humtsoe J.O., Feng S., Thakker G.D., Yang J., Hong J., Wary K.K. EMBO J. 22:1539-1554(2003) [PubMed: 12660161] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [4] | "Molecular cloning of and expression of an isoform of human phosphatidic acid phosphatase cDNA." Leung D.W., Tompkins C.K. Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [5] | "Large-scale concatenation cDNA sequencing." Yu W., Andersson B., Worley K.C., Muzny D.M., Ding Y., Liu W., Ricafrente J.Y., Wentland M.A., Lennon G., Gibbs R.A. Genome Res. 7:353-358(1997) [PubMed: 9110174] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Placenta. |
| [7] | "Lipid phosphate phosphatases dimerise, but this interaction is not required for in vivo activity." Burnett C., Makridou P., Hewlett L., Howard K. BMC Biochem. 5:2-2(2004) [PubMed: 14725715] [Abstract] Cited for: SUBUNIT. |
| [8] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-110, MASS SPECTROMETRY. Tissue: Epithelium. |
| [9] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-297, MASS SPECTROMETRY. |
| [10] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-297, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| AB000889 mRNA. Translation: BAA22594.1. AF017786 mRNA. Translation: AAC63433.1. AF480883 mRNA. Translation: AAO84481.1. AF043329 mRNA. Translation: AAD02271.1. U79294 mRNA. Translation: AAB50222.1. Frameshift. BC009196 mRNA. Translation: AAH09196.1. | |
| IPI | IPI00021453. |
| RefSeq | NP_003704.3. NP_803133.1. |
| UniGene | Hs.405156 Hs.708050 |
3D structure databases | |
| ModBase | Search... |
PTM databases | |
| PhosphoSite | O14495. |
Proteomic databases | |
| PRIDE | O14495. |
Genome annotation databases | |
| Ensembl | ENSG00000162407. Homo sapiens. [Contig view] |
| GeneID | 8613. |
| KEGG | hsa:8613. |
| UCSC | uc001cyj.1. human. |
Organism-specific databases | |
| GeneCards | GC01M056671. |
| H-InvDB | HIX0000628. |
| HGNC | HGNC:9229. PPAP2B. |
| MIM | 607125. gene. |
| PharmGKB | PA33553. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOGENOM | O14495. |
| HOVERGEN | O14495. |
| OMA | O14495. YIQNYRC. |
Enzyme and pathway databases | |
| BRENDA | 3.1.3.4. 247. |
| Reactome | REACT_602. Metabolism of lipids and lipoproteins. |
Gene expression databases | |
| ArrayExpress | O14495. |
| Bgee | O14495. |
| CleanEx | HS_PPAP2B. |
| GermOnline | ENSG00000162407. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR016118. P_Acid_Pase/Cl_peroxidase_N. IPR000326. P_Acid_Pase_2/haloperoxidase. [Graphical view] |
| Gene3D | G3DSA:1.20.144.10. P_Acid_Pase/Cl_peroxidase_N. 1 hit. |
| Pfam | PF01569. PAP2. 1 hit. [Graphical view] |
| SMART | SM00014. acidPPc. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 32277. |
| SOURCE | Search... |
Entry information
| Entry name | LPP3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O14495 Secondary accession number(s): Q96GW0, Q99782 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


